CG Oncology (NASDAQ: CGON) insider lines up new stock sale
Rhea-AI Filing Summary
CGON insider Ambaw Bellete filed a notice to sell common stock under Rule 144. The planned transaction lists 52,438 shares of common stock to be sold through Morgan Stanley Smith Barney LLC on 08/17/2026, in connection with a stock option exercise.
The filing also lists multiple prior open-market sales of CGON common stock by Ambaw Bellete during the past three months, including individual sales such as 75,000 shares on 08/06/2026 and several sales of 50,000 shares on various dates, each with stated dollar amounts.
Positive
- None.
Negative
- None.
Key Figures
Shares planned for sale: 52,438 shares
Dollar figure for planned sale: 4,034,894.35
Largest recent single sale: 75,000 shares
+3 more
6 metrics
Shares planned for sale
52,438 shares
Common stock to be sold on or after 08/17/2026 under Rule 144
Dollar figure for planned sale
4,034,894.35
Associated amount listed with 52,438 CGON shares in securities information
Largest recent single sale
75,000 shares
CGON common shares sold on 08/06/2026 during past three months
Amount from 08/06/2026 sale
5,672,212.50
Dollar amount reported for 75,000 CGON shares sold on 08/06/2026
Recent 50,000-share sale (08/11/2026)
3,810,255.00
Dollar amount reported for 50,000 CGON shares sold on 08/11/2026
Recent 50,000-share sale (08/10/2026)
3,770,580.00
Dollar amount reported for 50,000 CGON shares sold on 08/10/2026
Key Terms
Rule 144, stock option exercise, Securities To Be Sold, Securities Sold During The Past 3 Months
4 terms
Rule 144 regulatory
"144: Securities To Be Sold Common | 08/17/2026 | Stock Option Exercise"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
stock option exercise financial
"Common | 08/17/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
Securities To Be Sold regulatory
"144: Securities To Be Sold Common | 08/17/2026 | Stock Option Exercise"
Securities Sold During The Past 3 Months regulatory
"144: Securities Sold During The Past 3 Months AMBAW BELLETE"
FAQ
What does CGON’s latest Form 144 filing disclose?
The Form 144 for CGON discloses that insider Ambaw Bellete intends to sell 52,438 shares of CGON common stock on or after 08/17/2026. The shares are to be sold through Morgan Stanley Smith Barney LLC in connection with a reported stock option exercise.
What recent CGON stock sales has Ambaw Bellete reported in the past three months?
The Form 144 lists several past three-month sales of CGON common stock by Ambaw Bellete, including 75,000 shares on 08/06/2026 and multiple 50,000-share transactions on dates such as 08/10/2026 and 08/11/2026, each with corresponding dollar amounts reported.
AI-generated analysis. How Rhea-AI works. Not financial advice.